Urine is no longer considered to be sterile. After the existence of the microbiome was revealed through metagenomic analysis using next-generation sequencing, the relationship between characteristics of the microbiome and diseases have been studied and published in various journals. A microbiome exists in the urinary tract and is associated with urinary tract infection, malignancy of the genitourinary tract, and lower urinary tract symptoms. Based on the urine sampling method, sampling site, culture method, and sex, the characteristics of the microbiome vary. Most of the Lactobacillus species are identified mainly in women, and various other species are identified in men. These microorganisms can cause or prevent various diseases. Variations in the microbiome are seen in those with and without disease, and an asymptomatic status does not indicate the absence of microbes. This microbiome has been implicated in a variety of lower urinary tract symptoms and diseases, in particular, overactive bladder. The microbiome differs between patients with urgency and urge urinary incontinence and healthy individuals. There are many aspects of the microbiome yet to be studied in relation to other lower urinary tract symptoms.
MicrobiotaOveractive bladderBiomarkerINTRODUCTION
The term microbiota was first described by Lederberg and McCray, and ‘microbiome’ refers to the entire habitat, including the microorganisms such as bacteria, archaea, lower and higher eukaryotes, viruses, and their genome and surrounding environment [1]. Through next-generation sequencing (NGS) [2], in addition to the pathological strains previously confirmed through culture tests, many normal flora (microbiota) were identified. These microbial environments keep humans healthy, prevent diseases, and play a role in homeostasis. Changes in these environments cause diseases by disrupting homeostasis.
Microbiomes are commonly found in the skin, placenta, mammary glands, seminal fluids, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary tract, and gastrointestinal tract system [3,4]. In 2015, Kogan et al. [5] announced that human urine was not sterile. Many researchers have confirmed the existence of microbiota in the human urinary tract through metagenomics (DNA-dependent) and metaculturomics (culture-dependent) technologies. Previously, it was believed that urine is sterile and that uropathogens invaded and caused urinary tract infections (UTIs). However, as the existence of the microbiome in urine-the urobiome-was confirmed, a new paradigm for the pathogenesis of diseases was suggested. The urobiome plays a role in preventing infections caused by pathogens, forms a barrier, and is necessary to maintain a healthy urinary tract; it has helped us gain a deeper understanding of various diseases. Currently, the microbiome is being studied in various fields of urology, such as UTI, interstitial cystitis, and genitourinary tract malignancy.
In addition to UTIs, the notion that the microbiome is associated with various urinary tract diseases is gaining popularity, and its relationship with various lower urinary tract symptoms is being studied [6,7]. A precise understanding of the urobiome is necessary to understand and treat urinary diseases in relation to the microbiome.
Among the disease groups with lower urinary tract symptoms, there are diseases whose prevalence is increasing owing to aging of the population, and the representative disease among them is overactive bladder (OAB). In the absence of an obvious infection, overactive bladder syndrome is characterized by urinary urgency, with or without urgency urinary incontinence, and is usually accompanied by frequency and nocturia [8]. The cause of OAB remains unknown. However, obesity, caffeine intake, constipation, diabetes, poor mobility, and chronic pelvic pain may be risk factors [9,10]. The diagnosis is mainly based on the signs and symptoms after UTI or neurological deficit has been excluded. It has a prevalence of 9%–43% in women and 7%–27% in men, and the prevalence tends to increase with age. Originally, detrusor overactivity (DO) was believed to be the major pathophysiological cause of OAB. DO can either be ‘myogenic,’ where the detrusor muscle contracts due to autonomic stimulation, or ‘neurogenic,’ where detrusor contraction is induced by the urgency signal released by the central nervous system. Recently, as the importance of the urothelium and suburothelium has been emphasized; different approaches and analyses for pathophysiology have been developed. In terms of the urothelium/suburothelium, various elements are being studied, including the urinary microbiota or urobiome. Peyronnet et al. [11] reported the pathophysiological factors affecting OAB are metabolic syndrome, affective disorder, sex hormone deficiency, urinary microbiota, gastrointestinal functional disorder, and subclinical autonomic nervous system dysfunction. In this regard, we aimed to investigate the urobiome and its relevance in OAB.
WHAT IS UROBIOME?
The urobiome refers to the microbiome of the urinary tract [12]. Since there was a strong assumption that urine is sterile in healthy people, the microbiome of urine was not included in the initial Human Genome Project. However, as the microbiomes of other organs have been attracting attention, and various microbiomes have been identified in various environments since then, there is an increase in the research regarding the microbiome of the urinary tract and its involvement in urologic diseases. However, studies show different results depending on the study conditions, and there are some difficulties in matching these conditions for comparisons between studies. There are several criteria to be considered when conducting research, which are: (1) collection method, (2) sex, (3) age, and (4) specific diseases of each organ of the urinary tract.
METHODS USED FOR URINARY MICROBIOME ANALYSIS
Microorganism detection methods can be divided into culture-based and sequencing-based methods. Traditionally, microorganisms have been identified by a standard urine culture method using MacConkey agar or blood agar. Rapid-growing and aerobic microorganisms were mainly identified. However, there is a disadvantage to culture-based methods as anaerobic and slow-growing microorganisms cannot be cultured.
The existence of the microbiome was confirmed by metagenomic analysis using a method called NGS [13]. It is a sequencing-based method that identifies bacteria through DNA sequences rather than the traditional method of culturing bacteria. It is divided into 2 types, amplicon sequencing using ‘marker genes’ such as 16S rRNA subunit with 9 hypervariable regions, and shotgun sequencing to analyze the entire microbiome sequence [14]. The disadvantage of the sequencing methods is that the viability of the microbes cannot be confirmed. An enhanced quantitative urine culture (EQUC), as a traditional culture-based method, can identify bacteria that were previously difficult to identify and compensate for such shortcomings [15]. An EQUC is performed by incubating the sample that was cultured using blood, chocolate, and colistin-nalidixic acid agar for 48 hours at 35°C A disadvantage of EQUC is that it identifies a broad range of bacteria, requiring interpretation of the results between patients and healthy people. Therefore, it is recommended that 16S rRNA gene sequencing and EQUC be performed simultaneously.
PROBLEMS WITH URINE COLLECTION
The existence of a microbiome in urine has been established by NGS and has been drawing attention from researchers. The detection of the diversity of the microbiome is impacted by various factors, one often mentioned is the sample collection method [16]. Since the microbiome is greatly influenced by the surrounding environment, different results are achieved depending on where the sample used for the study was collected. Pohl et al. [17] reported that a different microbiome was identified in the urine that passed through both the bladder and urethra through self-voiding compared with the sample that bypassed the urethra through the catheter. Wolfe and Brubaker [18], ‘Is it self voiding?’ ‘Is it midstream?’ ‘Is it Catheterization?’ ‘Is it a blade puncture?’ Different results were obtained depending on the differences in the urinary tract through which the sample urine passed [18] (Fig. 1). In another study, there was no difference in the microbiome results between the first and mid streams [19]. This means that the microbiome in the urethral environment and the microbiome of the bladder are different, and whether the microbiome of the urethra is included impacts the results. Regarding the upper ureter, its microbiome is affected by changes in the microbial environment at the kidney level. Studies have shown that a decrease in estimated glomerular filtration rate reduces microbiome diversity [20].
Although the microbiome differs from individual to individual, depending on odor, method of sample collection, and sex, there is one important thing in common: there is a difference between asymptomatic and symptomatic patients. It is important to remember that an asymptomatic status does not indicate the absence of disease.
DIFFERENCES IN THE URINARY MICROBIOME BETWEEN MEN AND WOMEN
The male and female reproductive microbiomes are different [21]. In a recent study, it was confirmed that the microbiome found in the genital area of men and women was different before sexual intercourse, but was similar after sexual intercourse [22]. The urine microbiome also differs between men and women [17,23]. There are several studies that analyzed urine samples collected from healthy men and women using various methods, such as clean catch urine, transurethral catheter urine, suprapubic puncture, midstream urine, and first catch urine; the common discovery was that Lactobacillusmethods. However, in men, a heterogeneous result was obtained based on the sampling method (Table 1).
AGE
There is a controversy about age as a factor influencing the microbiome, there are reports of a lack of relevance [24] and correlation [3,25,26]. When checked if microbiome is directly affected by age, it was found that there was no significant age-related change; however, there was a difference between the young and old population [27,28]. Rather than considering age as a factor, the change in microbiome can be considered to be a secondary change associated with aging. Various changes in the body as a result of aging can cause changes in the environmental aspect of the microbiota, which affects microbiome diversity and commensal microorganisms, which can be seen not only in people with diseases but also in healthy people. In women, hormonal changes occur because of aging; therefore, menopause is an important criterion for change in the microbiome. It is evident that environmental changes in the vaginal microbiome caused by female hormones cause changes in the urobiome. According to several studies, Lactobacillus is abundant in the urine of premenopausal women, and less so in postmenopausal women. In addition, Mobiluncus spp. were found abundantly in postmenopausal women [24].
DISEASE-RELATED CHANGES IN THE URINARY MICROBIOME IN WOMEN IN RELATION TO CHANGES IN THE GUT MICROBIOME
Some urologic diseases in women are a result of the imbalance in the urobiome, such as: OAB syndrome, urge urinary incontinence (UUI), interstitial cystitis/bladder pain syndrome, asymptomatic bacteriuria, and neurogenic bladder dysfunction. Although there is no clear mechanism or association yet, many studies have shown a link between the disease and the microbiome [14,25,29-33]. Lactobacillus, which was identified as an important contributor in these diseases, changes the vaginal flora while also changing the gut microbiome through oral probiotics and causes diseases such as diarrhea in the gastrointestinal tract. These changes play a role in the prevention of UTIs. A recent study also reported that changes in the gut microbiota affect OAB and daily urgency [34]. There was a difference in the gut microbiota between the group with OAB symptoms and urgency and the asymptomatic group. It is common to consider the urinary microbiome to be an ascending infection of the gut. The urinary microbiome was found to be 62.5% similar to the gut microbiome and 32% similar to the vaginal microbiome; therefore, they are closely related to each other [16,35-37].
URINARY BIOMARKERS AND MICROBIOME IN OVERACTIVE BLADDER
In OAB syndrome, various urine biomarkers were extensively studied to distinguish phenotypes along with the diagnosis [3,4,38,39]. A representative example is nerve growth factor (NGF) and brain-derived neurotrophic factor, a neurotrophin that is produced in the urothelium or smooth muscle cells is widely used as a marker of lower urinary tract dysfunction. According to Suh et al. [40], urinary NGF increases in patients with OAB, hence is considered an important biomarker for the treatment of OAB. Another biomarker is microRNA in genomics. miRNAs have also been used as biomarkers for urothelial carcinoma in the urological field [41,42]. Some microRNAs, such as miR-103a-3p, miR-10a-5p, and miR-199a-3p, have been used as urinary biomarkers of DO or underactivity [43].
The interdependence between antimicrobial peptides (AMPs), specifically beta-adhesin AMP, and the microbiota increased the risk of UTI after surgery [44]. In addition, levels of prostaglandin E2 (PGE2), an inflammatory marker also increases in OAB [45]. PGE2 is also associated with bladder capacity, and its levels are significantly decreased after administration of intravesicular botulinum toxin A injection [46]. Furthermore, high levels of PEG2 are observed in UUI and is considered as a potential target for future treatment. Urinary adenosine triphosphate (ATP) is also involved in contraction and relaxation of the detrusor muscle, and in patients with OAB, it may be overexpressed or its concentration in urine may change [47,48]. Urinary b3-adrenoceptor (B3-AR) is involved in detrusor relaxation, and the Trp64Arg polymorphism in B3-AR is closely related to DO [49]. The urinary microbiome shows characteristics specific to the disease, a large number of specific strains are identified in diseases such as UUI across various samples. As a result, it can be used as a useful biomarker of urine if it is further standardized and researched based on a large number of subjects (Table 2).
CORRELATION BETWEEN OVERACTIVE BLADDER SYMPTOMS AND MICROBIOME
In the absence of a UTI, the signs and symptoms (urgency complaints) are diagnosed as a representative bladder storage disorder. However, as the urothelium/suburothelium is known to play an important role in pathophysiology of OAB, studies about the correlation between the symptoms and microbiome of OAB are being conducted. According to Peyronnet et al. [11], OAB phenotypes include metabolic syndrome, affective disorder, sex hormone deficiency, functional gastrointestinal disorder, autonomic nervous system dysfunction, and ‘urinary microbiota’ depending on the pathophysiological factors . It is also predicted that brain-bladder-microbiota amblyopia exists as the gut microbiota forms the brain-gut-microbiota axis.
However, it has not yet shown any significant results for each symptom, and the relationship with the microbiome has been revealed in some symptoms. In general, symptoms of OAB include frequency, urgency, nocturia, and urge incontinence. The role of the microbiome in each can be summarized as shown in Table 2. Studies have shown that there is a difference in the microbiome of patients diagnosed with OAB, regardless of the symptoms. According to Curtiss et al. [50], there is a study showing that Proteus was significantly abundant in patients with OAB compared to healthy people, and at the same time, Lactobacillus was less prevalent (Table 3).
Frequency
There are negligible number of papers that mention the correlation between frequency and the microbiome. However, when examining each symptom cluster using EQUC in patients UTI, the presence of Lactobacillus or Klebsiella among the symptom clusters with frequency symptoms were significantly prevalent compared to the asymptomatic group [51]. We concluded that more clear research is needed in this area.
Nocturia
Although the correlation between nocturia symptoms and the microbiome is unknown, Holland et al. [52] reported that nocturia was related to the International Prostate Symptom Score (IPSS). Lachnospiraceae Blautia in urinary operational taxonomy units has bothersome symptoms, is associated with severity, has protective effects in IPSS, and is also associated with nocturia.
Urgency
A study compared urgency with Overactive Bladder Symptom Score using the gut microbiome and not urine microbiome. In the OAB group, bacterial diversity was low, the Bifidobacterium group was low, and the Faecali bacterium group was abundant.
Urinary incontinence
Among the symptoms associated with OAB, urinary incontinence is the most studied and is the best-known symptom of microbiome imbalance [53]. Although incontinence and, in particular, UUI, are not essential symptoms of OAB, various studies have considered their relationship with DO [25,29,30,33,34,54-59].
Pearce et al. [29] compared patients with and without UUI symptoms and confirmed a difference in prevalence of Gardenerella and Lactobacillus. In the UUI group, presence of Gardnerella was high and Lactobacillus was low. In the same study, Lactobacillus spp. levels varied in the control group, Lactobacillus crispatus was high while Lactobacillus gasseri was low. In UUI, vaginal estrogen therapy in postmenopausal women resulted in a decrease in microbial diversity, a change in Lactobacillus levels in urine, and a change in UUI [60].
In addition to these strains, E. coli and some Gardnella vaginalis strains, classified as uropathogenic microorganisms, induce the release of calcium ions or ATP from the urothelial epithelium and are involved in the contraction of bladder smooth muscle cells, causing incontinence. In contrast, Lactobacillus has been reported to inhibit this process [61]. Furthermore, in patients with refractory UUI with recurrent UTI, diverse microbiota exists, but if colonization continues, the disease persists, so appropriate intervention is necessary [62].
There are studies on the role of the urobiome not only with respect to the presence or absence of UUI symptoms, but also to symptom severity. Karstens et al. [56] cultured bladder microbiomes of healthy individuals and individuals with UUI. The study identified 14 strains and established that there are differences in the relative abundance in healthy people and patients with UUI, and that the microbiome in individuals with UUI differed according to severity.
LIMITATION OF OAB RESEARCH USING THE MICROBIOME
There are several problems in studying the association between the symptoms of OAB, pathophysiology, and microbiome:
(1) It can be concluded that there is some association, but in some cases, there is uncertainty regarding the predominance of a specific microbiome in the diseased and nondiseased individuals, for example: Lactobacillus predominance does not differ between adult women with mixed urinary incontinence and age-matched asymptomatic women, but some members of the genus Lactobacillus might be associated with urinary symptoms [28].
(2) In many cases, the collected data are not suitable for studying the urobiome and data on a specific microbiome are insufficient or absent. Public databases are inadequate for studies of the urobiome and its relationship with bladder health and diseases because these databases lack urobiome-specific genomes [63]. This is due to the fact that the dominant microbiome is different under various environmental conditions. However, since there is a lack of standardization, several factors, such as the method and timing of sample collection, sex, and comorbidities, must be considered. Only when the research is conducted by considering all these aspects will it be possible to derive more reliable results on the relevance of a specific microbiome with respect to diseases or symptoms.
(3) It is necessary to standardize the sample, especially in men, and the urethral environment must be considered. Men with more severe urinary symptoms are more likely to have detectable bladder bacteria than those with few severe or no symptoms. Voided urine does not adequately characterize the male bladder urobiome and catheterized urine should be used instead [64].
(4) Studies with large sample sizes are scarce. More extensive and large-scale data is needed on samples of healthy and diseased individuals.
CONCLUSIONS
The discovery of the microbiome using NGS has completely changed the disease paradigm. Urine is not considered sterile anymore. In situations where association between various diseases of the urinary tract and the role of the urothelium are emerging, various clinical aspects of OAB have been shown closely related to the urobiome. Various approaches and considerations, such as the gut microbiome and vaginal flora, are required to study the relationship between the urobiome and OAB. However, since the size of the study and the sample size was not large enough, a clearer and more accurate analysis is needed through a larger-scale and harmonized research method.
Fund/Grant Support
This paper was written as part of Konkuk University’s research support program for its faculty on sabbatical leave in 2019.
Conflict of Interest
No potential conflict of interest relevant to this article was reported.
AUTHOR CONTRIBUTION STATEMENT
·Conceptualization: CH
·Data curation: BSR
·Formal analysis: BSR, CH
·Funding acquisition: BSR, CH
·Methodology: CH
·Project administration: CH
·Visualization: BSR
·Writing - original draft: BSR
·Writing - review & editing: BSR, CH
REFERENCESMarchesiJRRavelJThe vocabulary of microbiome research: a proposal2015331ParkSTKimJTrends in next-generation sequencing and a new era for whole genome sequencing201620Suppl 2S7683DrakeMJMorrisNApostolidisARahnama’iMSMarchesiJRThe urinary microbiome and its contribution to lower urinary tract symptoms; ICI-RS 20152017368503AragónIMHerrera-ImbrodaBQueipo-OrtuñoMICastilloEDel MoralJSGómez-MillánJThe urinary tract microbiome in health and disease2018412838KoganMINabokaYLIbishevKSGudimaIANaberKGHuman urine is not sterile - shift of paradigm20159444552KimAAhnJChoiWSParkHKKimSPaickSHWhat is the cause of recurrent urinary tract infection? Contemporary microscopic concepts of pathophysiology202125192201KimMSJungSIThe urinary tract microbiome in male genitourinary diseases: focusing on benign prostate hyperplasia and lower urinary tract symptoms202125311DrakeMJDo we need a new definition of the overactive bladder syndrome? ICI-RS 20132014336224Al-ShaijiTFRadomskiSBRelationship between body mass index and overactive bladder in women and correlations with urodynamic evaluation20121612631UzunHYilmazAKemikAZorbaOUKalkanMAssociation of insulin resistance with overactive bladder in female patients2012161816PeyronnetBMironskaEChappleCCardozoLOelkeMDmochowskiRA comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment2019759881000ShoemakerRKimJUrobiome: an outlook on the metagenome of urological diseases20216261122WolfeAJBrubakerL“Sterile urine” and the presence of bacteria2015681734FoutsDEPieperRSzpakowskiSPohlHKnoblachSSuhMJIntegrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury201210174PriceTKDuneTHiltEEThomas-WhiteKJKliethermesSBrincatCThe clinical urine culture: enhanced techniques improve detection of clinically relevant microorganisms201654121622Perez-CarrascoVSoriano-LermaASorianoMGutiérrez-FernándezJGarcia-SalcedoJAUrinary microbiome: yin and yang of the urinary tract202111617002PohlHGGroahSLPérez-LosadaMLjungbergISpragueBMChandalNThe urine microbiome of healthy men and women differs by urine collection method2020244151WolfeAJBrubakerLUrobiome updates: advances in urinary microbiome research201916734OzerMSYildizHAIncirCDegerMDBozkurtOErgorGUrinary microbiota; which non-ınvasive urine collection method should we use?202175e14193KramerHKuffelGThomas-WhiteKWolfeAJVellankiKLeeheyDJDiversity of the midstream urine microbiome in adults with chronic kidney disease201850112330KoedooderRMackensSBuddingAFaresDBlockeelCLavenJIdentification and evaluation of the microbiome in the female and male reproductive tracts201925298325GhemrawiMTorresARDuncanGColwellRDadlaniMMcCordBThe genital microbiome and its potential for detecting sexual assault202151102432LeeSJCommentary on “the urine microbiome of healthy men and women differs by urine collection method”2020241824CurtissNBalachandranAKrskaLPeppiatt-WildmanCWildmanSDuckettJAge, menopausal status and the bladder microbiome20182281269PearceMMZillioxMJRosenfeldABThomas-WhiteKJRichterHENagerCWThe female urinary microbiome in urgency urinary incontinence201513347.e111Thomas-WhiteKJGaoXLinHFokCSGhanayemKMuellerERUrinary microbes and postoperative urinary tract infection risk in urogynecologic surgical patients2018291797805LiuFLingZXiaoYYangQZhengLJiangPCharacterization of the urinary microbiota of elderly women and the effects of type 2 diabetes and urinary tract infections on the microbiota2017810067890KomesuYMRichterHECarperBDinwiddieDLLukaczESSiddiquiNYThe urinary microbiome in women with mixed urinary incontinence compared to similarly aged controls201829178595PearceMMHiltEERosenfeldABZillioxMJThomas-WhiteKFokCThe female urinary microbiome: a comparison of women with and without urgency urinary incontinence20145e0128314Thomas-WhiteKJHiltEEFokCPearceMMMuellerERKliethermesSIncontinence medication response relates to the female urinary microbiota20162772333SiddiquiHLagesenKNederbragtAJJeanssonSLJakobsenKSAlterations of microbiota in urine from women with interstitial cystitis201212205NeugentMLHulyalkarNVNguyenVHZimmernPEDe NiscoNJAdvances in understanding the human urinary microbiome and its potential role in urinary tract infection202011e0021820PriceTKLinHGaoXThomas-WhiteKJHiltEEMuellerERBladder bacterial diversity differs in continent and incontinent women: a cross-sectional study2020223729.e110OkamotoTHatakeyamaSImaiAYamamotoHYoneyamaTMoriKAltered gut microbiome associated with overactive bladder and daily urinary urgency20213984753ModenaBDMilamRHarrisonFCheesemanJAAbecassisMMFriedewaldJJChanges in urinary microbiome populations correlate in kidney transplants with interstitial fibrosis and tubular atrophy documented in early surveillance biopsies20171771223DiopKDufourJCLevasseurAFenollarFExhaustive repertoire of human vaginal microbiota201911100051MorandACornuFDufourJCTsimaratosMLagierJCRaoultDHuman bacterial repertoire of the urinary tract: a potential paradigm shift20195e0067518Antunes-LopesTCruzFUrinary biomarkers in overactive bladder: revisiting the evidence in 20192019532936SuhYSKoKJKimTHLeeHSSungHHChoWJPotential biomarkers for diagnosis of overactive bladder patients: urinary nerve growth factor, prostaglandin E2, and adenosine triphosphate2017211717SuhYSKoKJKimTHLeeHSSungHHChoWJUrinary nerve growth factor as a potential biomarker of treatment outcomes in overactive bladder patients20172127081SapreNMacintyreGClarksonMNaeemHCmeroMKowalczykAA urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance201611445462YunSJJeongPKangHWKimYHKimEAYanCUrinary microRNAs of prostate cancer: virus-encoded hsv1-miRH18 and hsv2-miR-H9-5p could be valuable diagnostic markers2015197484MonastyrskayaKBurkhardFCUrinary biomarkers for bladder outlet obstruction20171212937NienhouseVGaoXDongQNelsonDETohEMcKinleyKInterplay between bladder microbiota and urinary antimicrobial peptides: mechanisms for human urinary tract infection risk and symptom severity20149e114185KimJCParkEYHongSHSeoSIParkYHHwangTKChanges of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom20051287580ChuangYCYoshimuraNHuangCCWuMChiangPHChancellorMBIntravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats20095615966FordAPIn pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization20128326HarveyRASkennertonDENewgreenDFryCHThe contractile potency of adenosine triphosphate and ecto-adenosine triphosphatase activity in guinea pig detrusor and detrusor from patients with a stable, unstable or obstructed bladder200216812359QuHCZhangWLiuYLWangPAssociation between polymorphism of β3-adrenoceptor gene and overactive bladder: a meta-analysis2015142495501CurtissNBalachandranAKrskaLPeppiatt-WildmanCWildmanSDuckettJA case controlled study examining the bladder microbiome in women with Overactive Bladder (OAB) and healthy controls2017214315BurnettLAHochstedlerBRWeldonKWolfeAJBrubakerLRecurrent urinary tract infection: association of clinical profiles with urobiome composition in women202140147989HollandBKarrMDelfinoKDyndaDEl-ZawahryABraundmeier-FlemingAThe effect of the urinary and faecal microbiota on lower urinary tract symptoms measured by the International Prostate Symptom Score: analysis utilising next-generation sequencing202012590510AngeliniKJAn integrative review of current research on the role of the female urinary microbiota in overactive bladder symptoms20173794100GovenderYGabrielIMinassianVFichorovaRThe current evidence on the association between the urinary microbiome and urinary incontinence in women20199133BrubakerLWolfeAJMicrobiota in 2016: associating infection and incontinence with the female urinary microbiota201714724KarstensLAsquithMDavinSStaufferPFairDGregoryWTDoes the urinary microbiome play a role in urgency urinary incontinence and its severity?2016678KeQSLeeCLKuoHCRecurrent urinary tract infection in women and overactive bladder - is there a relationship?2021331321RichterHECarnesMUKomesuYMLukaczESAryaLBradleyMAssociation between the urogenital microbiome and surgical treatment response in women undergoing midurethral sling operation for mixed urinary incontinence202222693.e193.e15SiddiquiHLagesenKNederbragtAJEriLMJeanssonSLJakobsenKSPathogens in urine from a female patient with overactive bladder syndrome detected by culture-independent high throughput sequencing: a case report2014814853Thomas-WhiteKTaegeSLimeiraRBrincatCJoyceCJakobsenEEVaginal estrogen therapy is associated with increased Lactobacillus in the urine of postmenopausal women with overactive bladder symptoms2020223727.e111AbbasianBShairAO’GormanDBPena-DiazAMBrennanLEngelbrechtKPotential role of extracellular atp released by bacteria in bladder infection and contractility20194e0043919ChenZPhanMDBatesLJPetersKMMukerjeeCMooreKHThe urinary microbiome in patients with refractory urge incontinence and recurrent urinary tract infection201829177582Thomas-WhiteKForsterSCKumarNVan KuikenMPutontiCStaresMDCulturing of female bladder bacteria reveals an interconnected urogenital microbiota201891557BajicPVan KuikenMEBurgeBKKirshenbaumEJJoyceCJWolfeAJMale bladder microbiome relates to lower urinary tract symptoms2020637682SiddiquiHNederbragtAJLagesenKJeanssonSLJakobsenKSAssessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons201111244WolfeAJTohEShibataNRongRKentonKFitzgeraldMEvidence of uncultivated bacteria in the adult female bladder201250137683LewisDABrownRWilliamsJWhitePJacobsonSKMarchesiJRThe human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults2013341HiltEEMcKinleyKPearceMMRosenfeldABZillioxMJMuellerERUrine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder2014528716WuPChenYZhaoJZhangGChenJWangJUrinary microbiome and psychological factors in women with overactive bladder20177488GottschickCDengZLVitalMMasurCAbelsCPieperDHThe urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment2017599AbernethyMGRosenfeldAWhiteJRMuellerMGLewicky-GauppCKentonKUrinary microbiome and cytokine levels in women with interstitial cystitis20171295006WangHAltemusJNiaziFGreenHCalhounBCSturgisCBreast tissue, oral and urinary microbiomes in breast cancer201788812238RaniARanjanRMcGeeHSAndropolisKEPanchalDVHajjiriZUrinary microbiome of kidney transplant patients reveals dysbiosis with potential for antibiotic resistance20171815970MeriwetherKVLeiZSinghRGaskinsJHobsonDTGJalaVThe vaginal and urinary microbiomes in premenopausal women with interstitial cystitis/bladder pain syndrome as compared to unaffected controls: a pilot cross-sectional study2019992BreslerLPriceTKHiltEEJoyceCFitzgeraldCMWolfeAJFemale lower urinary tract microbiota do not associate with IC/PBS symptoms: a case-controlled study201930183542LiuFZhangNJiangPZhaiQLiCYuDCharacteristics of the urinary microbiome in kidney stone patients with hypertension202018130NelsonDEDongQVan der PolBTohEFanBKatzBPBacterial communities of the coronal sulcus and distal urethra of adolescent males20127e36298WuPZhangGZhaoJChenJChenYHuangWProfiling the urinary microbiota in male patients with bladder cancer in china20188167Bučević PopovićVŠitumMChowCTChanLSRojeBTerzićJThe urinary microbiome associated with bladder cancer2018812157KassiriBShresthaEKasprenskiMAntonescuCFloreaLDSfanosKSA prospective study of the urinary and gastrointestinal microbiome in prepubertal males201913120410XieJHuangJSHuangXJPengJMYuZYuanYQProfiling the urinary microbiome in men with calcium-based kidney stones20202041Figure and Tables
Differences in urine collection methods in relation to the urobiome (invasiveness and contamination). In the case of suprapubic puncture, only the microbiome of the bladder was identified, and the invasiveness was the highest. Conversely, self-voiding methods (first catch urine, midstream urine, and clean catch urine) are less invasive but are contaminated with microbiota from the urethral flora.
Strains identified in the urobiome according to sex and urine collection method
Microbial strains identified in urine samples collected from individuals with overactive bladder symptoms
Symptom
Study
Year
Microbial strains
Frequency
Burnett et al. [51]
2021
Few related studies in UTI, Lactobacillus or Klebsiella increased culture group has ‘frequency’ symptoms
Nocturia
Holland et al. [52]
2020
Urinary OUT related with Lachnospiraceae Blautia (protective correlation [negative correlation with symptom])
Urgency
Okamoto et al. [34]
2021
Bifidobacterium group was low, and the Faecali bacterium group was abundant in gut microbiome (not urobiome)
Urge incontinence
Pearce et al. [29]
2014
Increased Gardenerella and decreased Lactobacillus in UUI Lactobacillus subgroup, Lactobacillus crispatus low and Lactobacillus gasseri high in UUI
Thomas-White et al. [60]
2020
After vaginal estrogen therapy, decreased diversity and increased Lactobacillus
Abbasian et al. [61]
2019
Lactobacillus inhibit ATP and calcium ion release from urothelium and inhibit UUI decreased Lactobacillus, cannot inhibit bladder contraction, and UUI happen
Karstens et al. [56]
2016
14 Bacterial species identification in healthy and UUI decreased diversity has effects to symptom severity